JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Journal website Submission website

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

J NEUROL NEUROSUR PS

ISSN / eISSN

0022-3050 / 1468-330X

Aims and Scope

JNNP's ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson's disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. With early online publication, regular podcasts and an immense archive collection (with the longest half-life of any journal in clinical neuroscience), JNNP is a trail-blazer and not a follower.

Subject Area

CLINICAL NEUROLOGY

PSYCHIATRY

SURGERY

CiteScore

15.90

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Surgery	Q1	#3/495
Medicine - Psychiatry and Mental Health	Q1	#13/531
Medicine - Neurology (clinical)	Q1	#11/373

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
CLINICAL NEUROLOGY - SCIE	Q1
PSYCHIATRY - SCIE	Q1
SURGERY - SCIE	Q1

H-index

188

Country/Area of Publication

ENGLAND

Publisher

BMJ Publishing Group

Publication Frequency

Monthly

Annual Article Volume

153

Open Access

Contact

B M J PUBLISHING GROUP, BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND, WC1H 9JR

Popular journals in the same field
Recent articles

Clinical biomarker-based biological ageing and future risk of neurological disorders in the UK Biobank: (2023) Jonathan K L Mak, Christopher E McMurran, Sara Hägg

Exploring the cost-effectiveness of EBV vaccination to prevent multiple sclerosis in an Australian setting: (2023) Andrew J Palmer, Ting Zhao, Bruce V Taylor, Ingrid van der Mei, Julie A Campbell

Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease: (2023) Alessandro Bertini, Fiore Manganelli, Gian Maria Fabrizi, Angelo Schenone, Lucio Santoro, Tiziana Cavallaro, Matteo Tagliapietra, Marina Grandis, Stef...

Haemorrhagic myelitis as a manifestation of MOG antibody-associated disease: (2023) Jonathan Ciron, Damien Biotti, Chloé Bost, Fabrice Bonneville, Romain Marignier

Methodological considerations for observational studies of treatment effectiveness in neurology: a clinician’s guide: (2023) Tomas Kalincik, Izanne Roos, Sifat Sharmin, Charles B Malpas

Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels: (2023) Julie A Campbell, Ingrid van der Mei, Bruce V Taylor, Andrew J Palmer, Glen J Henson, Laura Louise Laslett, Steve Simpson-Yap, Suzi B Claflin

Are patients with GBA–Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort: (2023) Micol Avenali, Roberta Zangaglia, Giada Cuconato, Ilaria Palmieri, Alberto Albanese, Carlo Alberto Artusi, Marco Bozzali, Giovanna Calandra-Buonaura,...

Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy: (2023) Luuk Wieske, Milou R Michael, Sjors G J G in 't Veld, Allerdien Visser, Ivo N van Schaik, Filip Eftimov, Charlotte E Teunissen

Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort: (2023) Merel C Broers, Luuk Wieske, Ece Erdag, Cemre Gürlek, Carina Bunschoten, Pieter A van Doorn, Filip Eftimov, Krista Kuitwaard, Juna M de Vries, Marie-C...

Time to treat the climate and nature crisis as one indivisible global health emergency: (2023) Chris Zielinski

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

May I ask how long does it usually take for the first-instance verdict?

2023-07-18

Professional review, also very efficient.

2023-07-12

View All Reviews

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started